Updated Sep 05, 2019

Newborn Screening for Child Survival – Sickle Cell Disease

Part of Muhimbili University of Health and Allied Sciences (MUHAS)

The innovation has no owner

CLAIM IT

Focus Areas:

Health

HealthSEE LESS

Implemented In:

Tanzania

TanzaniaSEE LESS

1
Country Implemented In
Verified Funding
?

Innovation Description

Building on existing MUHAS programmes related to sickle cell supported, in part, by the Wellcome Trust, MUHAS is establishing a population based new-born screening (NBS) program to identify children at birth with Sickle Cell Disease (SCD) and other non-communicable diseases (NCDs). The main elements to the program are: (1) awareness raising and health education on SCD and NBS with focus on pregnant women; (2) NBS for SCD to 100,000 babies; (3) comprehensive care for children under 5 with strengthening of education and training on SCD and NBS for health workers; and (4) strengthening health systems and policy development for NBS. The program is being implemented in Dar es Salaam in collaboration with Amana Hospital, Temeke Hospital, Mwananyamala Hospital, and Muhimbili National Hospital.

Milestones

Jan 2015
Funds RaisedVERIFIED
$3,327,500
FOCUS AREAS
Health
IMPLEMENTED INTanzania
Date Unknown
New Country Implemented In
Tanzania